The HER2 Flip: HER2 Amplification of Tumor Cells in the Cerebrospinal Fluid (CSF-TCs) of Patients with Leptomeningeal Metastasis Having Solid Tumors; Implications for Treating the LM Tumor with Anti_HER2 Therapy Society for Neuro-Oncology 2022BioceptNovember 22, 2022
The Detection of Disseminated Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) in Cerebrospinal Fluid (CSF) Using Cell Capture and Immunocytochemistry Society for Neuro-Oncology 2022BioceptNovember 22, 2022
Detection of Mutant p53 Positive Glioblastoma Cells in Cerebrospinal Fluid (CSF) Using a Microfluidic Based Immunoassay Society for Neuro-Oncology 2022BioceptNovember 22, 2022
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay Clinical Breast Cancer 2022BioceptAugust 26, 2022
Using Cerebrospinal Fluid Tumor Cell (CSF-TC) Assays to Track Disease Burden and Treatment Response in Patients with Leptomeningeal Metastasis American Academy of Neurology 2022BioceptApril 7, 2022
